Skip to main content

Celia Crane LaBranche, PhD

Publications

Antanasijevic, Aleksandar, Leigh M. Sewall, Christopher A. Cottrell, Diane G. Carnathan, Luis E. Jimenez, Julia T. Ngo, Jennifer B. Silverman, et al. “Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM.” Nature Communications 12, no. 1 (August 10, 2021): 4817. https://doi.org/10.1038/s41467-021-25087-4.

Full Text

Pino, Maria, Talha Abid, Susan Pereira Ribeiro, Venkata Viswanadh Edara, Katharine Floyd, Justin C. Smith, Muhammad Bilal Latif, et al. “A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.” Sci Immunol 6, no. 61 (July 15, 2021). https://doi.org/10.1126/sciimmunol.abh3634.

Full Text

Cai, Fangping, Wei-Hung Chen, Weimin Wu, Julia A. Jones, Misook Choe, Neelakshi Gohain, Xiaoying Shen, et al. “Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.” Plos Pathog 17, no. 6 (June 2021): e1009624. https://doi.org/10.1371/journal.ppat.1009624.

Full Text

Wells, Lauren, Cory Vierra, Janee’ Hardman, Yanxiao Han, Dustin Dimas, Lucia N. Gwarada-Phillips, Rachel Blackeye, et al. “Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2.” Adv Ther (Weinh), February 12, 2021, 2000210. https://doi.org/10.1002/adtp.202000210.

Full Text

Vierra, Cory, Daryl K. Eggers, Celia C. LaBranche, and Katherine D. McReynolds. “An Efficient Microwave-Mediated Synthesis of Hexavalent Sialic Acid Sulfoglycodendrimers as Potential Anti-HIV Agents.” Acs Appl Polym Mater 2, no. 11 (November 13, 2020): 4345–51. https://doi.org/10.1021/acsapm.0c00538.

Full Text